Австралия - английски - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - bosentan monohydrate, quantity: 129.08 mg (equivalent: bosentan, qty 125 mg) - tablet, film coated - excipient ingredients: maize starch; pregelatinised maize starch; sodium starch glycollate type a; povidone; magnesium stearate; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red - bosentan gh is indicated for the treatment of ? idiopathic pulmonary arterial hypertension ? familial pulmonary arterial hypertension ? pulmonary arterial hypertension associated with scleroderma or ? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger?s physiology,in patients with who functional class ii, iii or iv symptoms.

Австралия - английски - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - bosentan monohydrate, quantity: 64.54 mg (equivalent: bosentan, qty 62.5 mg) - tablet, film coated - excipient ingredients: maize starch; pregelatinised maize starch; magnesium stearate; sodium starch glycollate type a; povidone; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red - bosentan gh is indicated for the treatment of ? idiopathic pulmonary arterial hypertension ? familial pulmonary arterial hypertension ? pulmonary arterial hypertension associated with scleroderma or ? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger?s physiology,in patients with who functional class ii, iii or iv symptoms.

Австралия - английски - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - bosentan monohydrate, quantity: 129.08 mg (equivalent: bosentan, qty 125 mg) - tablet, film coated - excipient ingredients: pregelatinised maize starch; povidone; maize starch; magnesium stearate; sodium starch glycollate type a; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red - bosentan gh is indicated for the treatment of ? idiopathic pulmonary arterial hypertension ? familial pulmonary arterial hypertension ? pulmonary arterial hypertension associated with scleroderma or ? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger?s physiology,in patients with who functional class ii, iii or iv symptoms.

Австралия - английски - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - bosentan monohydrate, quantity: 64.54 mg (equivalent: bosentan, qty 62.5 mg) - tablet, film coated - excipient ingredients: maize starch; magnesium stearate; sodium starch glycollate type a; povidone; pregelatinised maize starch; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red - bosentan gh is indicated for the treatment of ? idiopathic pulmonary arterial hypertension ? familial pulmonary arterial hypertension ? pulmonary arterial hypertension associated with scleroderma or ? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger?s physiology,in patients with who functional class ii, iii or iv symptoms.

Австралия - английски - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - hydroxychloroquine sulfate, quantity: 200 mg - tablet - excipient ingredients: hypromellose; magnesium stearate; calcium hydrogen phosphate; polysorbate 80; colloidal anhydrous silica; pregelatinised maize starch; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - rheumatoid arthritis; mild systemic and discoid lupus erythematosus; the suppression and treatment of malaria.

Австралия - английски - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - leflunomide, quantity: 20 mg - tablet, film coated - excipient ingredients: magnesium stearate; crospovidone; maize starch; povidone; colloidal anhydrous silica; lactose monohydrate; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000 - leflunomide generichealth is indicated for the treatment of: - active rheumatoid arthritis; - active psoriatic arthritis. leflunomide generichealth is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease.,the combined use of leflunomide generichealth with other disease modifying anti-rheumatic drugs (dmards) has not been adequately studied (see precautions).

Австралия - английски - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - leflunomide, quantity: 10 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; povidone; crospovidone; magnesium stearate; lactose monohydrate; maize starch; titanium dioxide; hypromellose; macrogol 4000 - leflunomide generichealth is indicated for the treatment of: - active rheumatoid arthritis; - active psoriatic arthritis. leflunomide generichealth is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease.,the combined use of leflunomide generichealth with other disease modifying anti-rheumatic drugs (dmards) has not been adequately studied (see precautions).

Австралия - английски - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - telmisartan, quantity: 80 mg - tablet - excipient ingredients: sodium hydroxide; mannitol; magnesium stearate; sodium stearylfumarate; povidone; meglumine - telmisartan gh is indicated for:,treatment of hypertension,prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Австралия - английски - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: mannitol; meglumine; sodium hydroxide; povidone; sodium stearylfumarate; magnesium stearate - telmisartan gh is indicated for:,treatment of hypertension,prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Австралия - английски - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - telmisartan, quantity: 80 mg; hydrochlorothiazide, quantity: 25 mg - tablet, multilayer - excipient ingredients: mannitol; povidone; magnesium stearate; purified water; sodium hydroxide; sodium stearylfumarate; meglumine; lactose monohydrate; colour - telmisartan hct gh is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.